Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
It is well understood that current Western screening and diagnostic processes commonly identify patients with low volume, low Gleason grade prostate cancer tumors (e.g., a single biopsy core with < 10 percent of the core positive for cancer of Gleason score 3 + 3 = 6).
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: candidate, focal therapy, incidence, risk, selection | 12 Comments »
The annual cancer statistics report from the American Cancer Society (Cancer Facts & Figures 2011) has just been released. The report is projecting 240,890 new cases of prostate cancer diagnosis and 33,720 prostate cancer-specific deaths in 2011. These numbers are up, yet again, from the projections for 2010.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: 2011, estimates, incidence, mortality | 4 Comments »
A new report has suggested that there will be a 201 percent increase in the annual number of prostate cancer diagnoses in Canada between 2009 and 2021.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Canada, Diagnosis, incidence, mortality, risk | 1 Comment »
A paper in the July issue of Psychological Science addresses the influence of men’s perceptions on their willingness to be tested for prostate cancer (at least in one part of Germany).
Filed under: Diagnosis, Risk, Uncategorized | Tagged: incidence, perception, risk, screening, testing | Leave a Comment »
A new epidemiological analysis of data from Denmark, Finland, Norway, and Sweden suggests that despite a significant increase in the incidence of prostate cancer (the number of men diagnosed each year), prostate cancer-specific mortality rates have been minimally affected over the past 40 years in these four countries.
Filed under: Diagnosis, Risk | Tagged: incidence, mortality, risk, Scandinavia | 6 Comments »
The latest data from the American Cancer Society suggest that there will be an increase in both prostate cancer diagnoses and prostate cancer deaths in the USA in 2010 compared to 2009,
Filed under: Diagnosis, Risk | Tagged: 2010, incidence, mortality, new diagnoses | 2 Comments »
The recently announced GLOBOCAN 2008 assessment of the worldwide burden of cancer includes a global estimate of 258,000 deaths from prostate cancer in 2008, and a global incidence of 913,000 cases of prostate cancer that same year.
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: epidemiology, incidence, mortality | 7 Comments »
Today’s news reports comment on: Prostate cancer incidence in Asia vs. the West PSA density as a risk factor for upgrading after surgery The mechanisms of progression of CRPC
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Asia, CRPC, incidence, progression, PSA density, upgrading | Leave a Comment »
The Prostate Testing for Cancer and Treatment (ProtecT) trial is being implemented in the UK to evaluate outcomes of three different types of treatment: surgery, radiation, and “active monitoring” in the management of localized prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: incidence, ProtecT, risk, screening, UK | Leave a Comment »
The cancer registry for the state of Schleswig-Holstein (the northernmost state of Germany), which has a population of 2.8 million inhabitants, has recently reported data on the incidence and mortality of prostate cancer for the years 1999 through 2005.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Germany, incidence, mortality, PSA, screening | 7 Comments »
Only two news reports of any significance this weekend, on: Pesticides and prostate cancer risk in Martinique The transition from hormone-sensitive to hormone-refractory disease
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment, Uncategorized | Tagged: castration-resistant, hormone refractory, hormone-sensitive, incidence, Martinique, pesticides, risk | Leave a Comment »
Today’s news reports address items on: The burden of prostate cancer in Canada Pelvic lymph node dissection and RALP Data from early trials of sipuleucel-T in advanced prostate cancer Implementation of osteoporosis screening guidelines in prostate cancer patients
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Canada, guidelines, incidence, mortality, osteoporesis, pelvic lymph node dissection, PLND, Provenge, screening, sipuleucel-T | 3 Comments »
A paper just published in the Journal of Clinical Oncology ( and available in full on line) includes data projecting 382,000 new cases of prostate cancer in the USA in 2030.
Filed under: Diagnosis, Prevention, Risk | Tagged: epidemiology, incidence | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site